Cargando…

Brain natriuretic peptide in pulmonary arterial hypertension: biomarker and potential therapeutic agent

B-type natriuretic peptide (BNP) is a member of the natriuretic peptide family, a group of widely distributed, but evolutionarily conserved, polypeptide mediators that exert myriad cardiovascular effects. BNP is a potent vasodilator with mitogenic, hypertrophic and pro-inflammatory properties that i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Casserly, Brian, Klinger, James R
Formato:	Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2009
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2802126/ https://www.ncbi.nlm.nih.gov/pubmed/20054445

Ejemplares similares

Ambrisentan for the treatment of pulmonary arterial hypertension
por: Casserly, Brian, et al.
Publicado: (2009)

Intrinsic defence capacity and therapeutic potential of natriuretic peptides in pulmonary hypertension associated with lung fibrosis
por: Baliga, R S, et al.
Publicado: (2014)

The Utility of Brain Natriuretic Peptide in Patients Undergoing an Initial Evaluation for Pulmonary Hypertension
por: Rao, Sanjana, et al.
Publicado: (2022)

Manipulating the natriuretic peptide system for the treatment of pulmonary hypertension
por: Baliga, Reshma S, et al.
Publicado: (2009)

Brain Natriuretic Peptide Biomarkers in Current Clinical and Therapeutic Scenarios of Heart Failure
por: Alcidi, Gianmarco, et al.
Publicado: (2022)

Comparison of Brain Natriuretic Peptide Levels to Simultaneously Obtained Right Heart Hemodynamics in Stable Outpatients with Pulmonary Arterial Hypertension
por: Helgeson, Scott A., et al.
Publicado: (2018)

The Association of N-Terminal Pro-Brain Natriuretic Peptide With Time to Clinical Worsening in Hispanic Patients With Pulmonary Arterial Hypertension
por: Khatab, Yacoub, et al.
Publicado: (2022)

Constitutively active form of natriuretic peptide receptor 2 ameliorates experimental pulmonary arterial hypertension
por: Nawa, Nobutoshi, et al.
Publicado: (2016)

Potential biomarkers and therapeutic targets of idiopathic pulmonary arterial hypertension
por: He, Wenjun, et al.
Publicado: (2022)

Differential effects of atrial and brain natriuretic peptides on human pulmonary artery: An in vitro study
por: Hussain, Azar, et al.
Publicado: (2019)

Reduced immunoreactivities of B-type natriuretic peptide in pulmonary arterial hypertension rats after ranolazine treatment
por: Lee, Jae Chul, et al.
Publicado: (2016)

C-Type Natriuretic Peptide Ameliorates Lipopolysaccharide-Induced Cardiac Dysfunction in Rats with Pulmonary Arterial Hypertension
por: Gao, Xiaowei, et al.
Publicado: (2018)

Endothelial actions of atrial natriuretic peptide prevent pulmonary hypertension in mice
por: Werner, Franziska, et al.
Publicado: (2016)

Human genetics, natriuretic peptides and hypertension
por: Newton-Cheh, Christopher
Publicado: (2011)

Heads and Tails of Natriuretic Peptides: Neuroprotective Role of Brain Natriuretic Peptide
por: Fernández‐Susavila, Héctor, et al.
Publicado: (2017)

Elevated pulmonary artery pressure and brain natriuretic peptide in high altitude pulmonary edema susceptible non-mountaineers
por: Gupta, Rajinder K., et al.
Publicado: (2016)

Prognostic value of brain natriuretic peptide in acute pulmonary embolism
por: Coutance, Guillaume, et al.
Publicado: (2008)

Association of brain natriuretic peptide gene polymorphisms with chronic obstructive pulmonary disease complicated with pulmonary hypertension and its mechanism
por: Jin, Guangjun, et al.
Publicado: (2018)

Utility of point-of-care testing of natriuretic peptides (brain natriuretic peptide and n-terminal pro-brain natriuretic peptide) in the emergency department
por: Nayer, Jamshed, et al.
Publicado: (2014)

Correction to: Endothelial actions of atrial natriuretic peptide prevent pulmonary hypertension in mice
por: Werner, Franziska, et al.
Publicado: (2022)

Plasma brain natriuretic peptide is a biomarker for screening ischemic cerebral small vessel disease in patients with hypertension
por: Wei, Weimin, et al.
Publicado: (2018)

N-terminal pro-brain natriuretic peptide levels in patients with anomalous left coronary artery from pulmonary artery
por: Yunfei, Ling, et al.
Publicado: (2020)

Natriuretic peptides: Diagnostic and therapeutic use
por: Pandit, Kaushik, et al.
Publicado: (2011)

Chronic natriuretic peptide protein therapeutics
por: Chen, Horng H, et al.
Publicado: (2013)

Innovative Therapeutics: Designer Natriuretic Peptides
por: Meems, Laura M.G., et al.
Publicado: (2016)

Cardiac Natriuretic Peptides, Hypertension and Cardiovascular Risk
por: Sarzani, Riccardo, et al.
Publicado: (2017)

A review of therapeutic agents for the management of pulmonary arterial hypertension
por: Hahn, Stella S, et al.
Publicado: (2016)

N-terminal pro brain natriuretic peptide in coronary artery disease
por: Tin, Sim Sai, et al.
Publicado: (2015)

N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study
por: Thakkar, Vivek, et al.
Publicado: (2012)

Diagnosis and Management of Pulmonary Arterial Hypertension
por: Houtchens, Jeanne, et al.
Publicado: (2011)

N-terminal pro-brain natriuretic peptide as a biomarker for predicting coronary artery lesion of Kawasaki disease
por: Zheng, Xiaolan, et al.
Publicado: (2020)

Brain natriuretic peptide in acute brain diseases
por: Špatenková, V, et al.
Publicado: (2003)

Natriuretic peptide biomarkers in the imminent development of preeclampsia
por: Marek-Iannucci, Stefanie, et al.
Publicado: (2023)

The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study
por: Thakkar, Vivek, et al.
Publicado: (2013)

The association of the N-terminal pro-brain-type natriuretic peptide response to exercise with disease severity in therapy-naive pulmonary arterial hypertension: a cohort study
por: Kutsch, J., et al.
Publicado: (2018)

Association of N-Terminal Pro Brain Natriuretic Peptide and Long-Term Outcome in Patients With Pulmonary Arterial Hypertension: Insights From the Phase III GRIPHON Study
por: Chin, Kelly M., et al.
Publicado: (2019)

Reply to: N-terminal pro brain natriuretic peptide in coronary artery disease
por: Radwan, Hanan, et al.
Publicado: (2015)

Atrial natriuretic peptide gene - a potential biomarker for long QT syndrome
por: Qureshi, Sameera Fatima, et al.
Publicado: (2014)

Brain Natriuretic Peptide Production and Secretion in Inflammation
por: Ogawa, Tsuneo, et al.
Publicado: (2012)

Brain natriuretic peptide among stroke patients
por: Saritas, Ayhan, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_np1kmr4tiqaa075f237sak9k6a